Not all cancer cells are the same, and neither are their responses to drugs. Finding the right drug for the right cancer cell is a long battle in drug development and in designing effective treatments ...

The collaboration with C-MET brings together C-MET's research and development expertise with Lord's Mark's manufacturing and ...

A Korean research team has reported that artificial intelligence (AI) used in mammography missed 14% of invasive breast cancers, the type where delayed diagnosis can directly impact patient survival.

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. Over the next 12 months, tens of thousands of women across ...

Following years of clinical validation and proven real-world performance at Saint Göran, Stockholm Region adopts Lunit INSIGHT MMG as an ...

In a major breakthrough, a team of researchers from The City College of New York and Memorial Sloan Kettering Cancer Center (MSKCC) has developed a new AI model that can detect breast cancer in MRI ...

Breast Suite is an industry-leading, comprehensive, and modular AI-powered suite of applications supporting more than 10 million mammograms annually delivering increased breast cancer detection ...

Hologic has released more data bolstering the use of its mammography AI for detecting breast cancer. (thomasandreas/iStock/Getty Images Plus) Hologic has put forward ...

This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being and SDG 9: Industry, Innovation and Infrastructure. Artificial intelligence (AI) has emerged as a ...

Breast cancer is the most common cancer among women, with over 2.3 million new cases diagnosed each year. Traditional diagnostic methods rely heavily on human judgment, which can lead to inconsistent ...